The observation that substituted purines, particularly
6-dimethylaminopurine (6-DMAP) (85; Scheme 17) and isopentenyladenine (86; Scheme 17), from Castanea species, showed weak inhibition of cyclin-dependent kinase 1 (CDK1)/ cyclin B, which led to the search for other purine-derived compounds